|
|
Small Stocks, Big Money™
|
Weekly Newsletter
|
|
|
|
|
|
|
|
LOBO Projects Margin Gains and 80% Revenue Growth in 2024
LOBO EV Technologies (Nasdaq: LOBO) expects 80% year-over-year revenue growth for 2024, fueled by expanded production capacity, new product launches, and market entry into Eastern Europe and Latin America. CEO Huajian Xu highlighted the company’s strategic investments and innovation efforts as key growth drivers, with margin improvements expected in the second half of the year due to operational efficiencies. LOBO’s focus on cutting-edge electric vehicle solutions and global expansion positions the company for continued success in a rapidly evolving market.
|
|
|
Gorilla Technology Partners with NC Digy, AECOM, and Protactics to Drive Smart City Growth in Latin America and the U.S.
Gorilla Technology (Nasdaq: GRRR) announced a strategic partnership with NC Digy Smart Cities, AECOM, and Protactics to advance smart city development in Latin America and the U.S. The collaboration aims to deploy AI-driven analytics and cybersecurity solutions alongside AECOM's infrastructure expertise, enhancing urban safety, efficiency, and sustainability. With rapid urbanization in Latin America and growing demand for smart city solutions in the U.S., this partnership is set to capitalize on significant growth opportunities in the evolving urban landscape.
|
|
|
|
Trinity Biotech Reports Positive Pre-Pivotal Trial Results for Next-Gen Continuous Glucose Monitor
Trinity Biotech (Nasdaq: TRIB) announced successful pre-pivotal trial results in Europe for its next-generation continuous glucose monitor (CGM) technology, which combines enhanced accuracy with a modular design to improve user experience and reduce costs. The study validated key improvements, including a shorter biosensor wire, showing favorable performance metrics. These results will guide further refinements, with a second pre-pivotal trial scheduled for later this year. Positioned to capture a significant share of the $20 billion CGM market by 2029, Trinity Biotech is advancing toward a pivotal trial in 2025.
|
|
|
|
|
|
BullFrog AI Announces Promising Data for Liver Disease Treatment Candidate BF-114
BullFrog AI (Nasdaq: BFRG) announced new research published in Cell Reports supporting the potential of its liver disease treatment candidate, BF-114, in addressing obesity-related liver conditions such as MASLD, MASH, and hepatocellular carcinoma (HCC). The study, led by renowned liver disease expert Dr. Lopa Mishra, reveals that targeting the β2-spectrin protein with BF-114 can prevent disease progression. Dr. Mishra has also joined BullFrog AI's Scientific Advisory Board to help advance BF-114, which aims to meet significant unmet needs in liver disease treatment.
|
|
|
|
Nova Minerals Announces High-Grade Gold Intercepts at Estelle Project in Alaska
Nova Minerals (Nasdaq: NVA) reported impressive results from its 2024 drilling program at the RPM deposit within the Estelle Gold-Antimony Project in Alaska. Highlights include 41m @ 4.6 g/t Au from surface, with significant near-surface high-grade intersections, including 2m @ 39.2 g/t Au. The program, focused on shallow mineralization, supports ongoing feasibility studies for the RPM starter mine, which aims to provide early cash flow for future expansion. With the deposit open for further exploration, Nova Minerals continues to advance its path toward production at its flagship Estelle Project.
|
|
|
|
|
|
Recent Research Coverage Updates
Company |
Rating |
Price Target |
Firm |
Report Date |
ASP Isotopes (Nasdaq: ASPI) |
Buy |
$4.50 |
Cannacord Genuity |
October 4, 2024 |
LOBO EV (Nasdaq: LOBO) |
Buy |
$5 |
Zacks Small-Cap Research |
May 15, 2024 |
GreenPower Motor (Nasdaq: GP) |
Buy |
$1.65 |
Roth |
August 15, 2024 |
Enlivex Therapeutics (Nasdaq: ENLV) |
Buy |
$13 |
EF Hutton |
August 27, 2024 |
GreenPower Motor (Nasdaq: GP) |
Buy |
$3 |
RF Lafferty |
September 11, 2024 |
GreenPower Motor (Nasdaq: GP) |
Buy |
$5 |
Maxim |
July 2, 2024 |
GreenPower Motor (Nasdaq: GP) |
Hold |
n/a |
BTIG |
July 1, 2024 |
GreenPower Motor (Nasdaq: GP) |
Buy |
$3 |
Roth |
April 1, 2024 |
BioVie (Nasdaq: BIVI) |
Buy |
$3 |
ThinkEquity |
July 1, 2024 |
Calidi Biotherapeutics (NYSE American: CLDI) |
Buy |
$1 |
Ladenburg Thalman |
June 27, 2024 |
Calidi Biotherapeutics (NYSE American: CLDI) |
Buy |
$1 |
Rodman & Renshaw |
June 27, 2024 |
Calidi Biotherapeutics (NYSE American: CLDI) |
Buy |
$2 |
RW Baird |
May 14, 2024 |
Unusual Machines (NYSE American: UMAC) |
Buy |
n/a |
ThinkEquity |
June 17, 2024 |
Soligenix (Nasdaq: SNGX) |
n/a |
$4.15 |
Zacks Research |
June 14, 2024 |
Enlivex Therapeutics (Nasdaq: ENLV) |
Buy |
$6 |
HC Wainwright |
June 11, 2024 |
Sixty Degrees Pharma (Nasdaq: SXTP) |
Hold |
n/a |
HC Wainwright |
June 6, 2024 |
Sixty Degrees Pharma (Nasdaq: SXTP) |
Buy |
n/a |
Ascendiant |
May 21, 2024 |
American Resources (Nasdaq: AREC) |
Buy |
n/a |
HC Wainwright |
June 3, 2024 |
|
|
|
|
|
Small Stocks, Big Money™ Podcast
The podcast features in-depth interviews with CEO’s from the top names in small-cap stocks, providing listeners with a unique perspective not found anywhere else.
Available on:
|
|
|
|
Upcoming Events
|
|
NASDAQ: AENT - Alliance Entertainment Holding
4:15pm Eastern
Alliance Entertainment is the global leader in physical media distribution, acting as the crucial gateway between major content producers and retailers.
|
|
|
NASDAQ: NTRB - Nutriband Inc.
4:15pm Eastern
Nutriband Inc is primarily engaged in the development of a portfolio of transdermal pharmaceutical products.
|
|
|
|
Archived Events
|
|
NASDAQ: NVA - Nova Minerals Limited
4:15pm Eastern
Nova Minerals is a gold, antimony and critical Minerals exploration and development company focused on advancing the Estelle Project.
|
|
|
|
Quote of the Week
|
"Even being right 3 or 4 times out of 10 should yield a person a fortune, if he has the sense to cut his losses quickly on the ventures he has been wrong."
|
|
|
|
|
RedChip TV
|
|
RedChip TV Highlights Genetic Technologies (NASDAQ: GENE) & BioVie (NASDAQ: BIVI)
|
|
|
|
|
|
|
Order "Small Stocks, Big Money™ Today!
Dave Gentry's new book, Small Stocks, Big Money: Interviews With Microcap Superstars, is now available for pre-order. Published by Wiley Finance, this first-hand perspective and insider information on the fast world of microcap investing is now available for purchase.
|
|
|
|
|
Lesson of the Week
The importance of liquidity in small-cap stocks.
|
|
|
|
MidSouth Week in Review
Wholesale gas is up 13% in the last month closing at $2.15 from the low of $1.90. Poor inflation rises to 2.8%, above expectations of 2.7%.
|
|
|
|
|
|
|
|